An Open-Label, Phase II, Randomized, Controlled Study of Danvatirsen Plus Pembrolizumab Compared to Pembrolizumab Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
CTRC Inpatient
Highlands Ranch Hospital
University of Colorado Hospital
Principal Investigator
![Photograph of Antonio Jimeno](https://som.ucdenver.edu/FIMS/Content/faculty/3752/CU-Doctors-3752.jpg)
Antonio Jimeno
Study ID
Protocol Number: 23-1812
More information available at ClinicalTrials.gov: NCT05814666
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers